Matthew Blackburn

Hematology | Oncology

1130 Nw 22nd Ave
Portland, OR 97210

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109.

Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109.

Journal: Cancers

Published: July 18, 2022

Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.

Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: April 14, 2022

The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.

The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 22, 2022

Evolving role of immunotherapy in small cell lung cancer.

Evolving role of immunotherapy in small cell lung cancer.

Journal: Seminars in cancer biology

Published: January 04, 2022

Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.

Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.

Journal: Cancers

Published: October 24, 2021

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.

Journal: Journal for immunotherapy of cancer

Published: September 20, 2021

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.

Journal: Cancer

Published: November 12, 2020

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection.

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection.

Journal: Journal for immunotherapy of cancer

Published: July 05, 2019

Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials.

Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials.

Journal: Breast cancer research and treatment

Published: October 24, 2017

Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Journal: Nature medicine

Published: October 07, 2016

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Journal: Nature medicine

Published: November 25, 2015

Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120.

Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: October 23, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026